Release Date: 17/10/16 17:05 Summary: Announcement of buy-back - Appendix 3C-AUF.AX Price Sensitive: Yes Download Document 85.62KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status